Carlos Villa Joins Versiti Blood Research Institute
Versiti Blood Research Institute shared on LinkedIn:
”Please welcome Carlos Villa, MD, PhD to VBRI!
Carlos Villa is joining the Translational Hematology Program as a Transfusion Medicine Clinician Investigator.
He joins Versiti from the US Food and Drug Administration where, most recently, he was the Associate Director for Special Programs in the Office of Blood Research and Review at CBER.
In that role, he contributed to regulatory, policy, and research initiatives to advance the safety and effectiveness of blood and blood components.
His clinical background is in Clinical Pathology and Transfusion Medicine, and his research has spanned basic sciences to clinical medicine, with experience in pharmacology and drug delivery.
He completed his MD/PhD training at the Tri Institutional program at Weill Cornell and Memorial Sloan Kettering, which was followed by residency and fellowship training at the University of Pennsylvania.”
Stay updated with Hemostasis Today.
-
Apr 5, 2026, 19:00Kausik Ray: Comparing Lipid Management in France vs. Rest of Europe for High Cardiovascular Risk Patients
-
Apr 5, 2026, 18:22Omar Adwan: Systematic Approach to Blood Smear Examination
-
Apr 5, 2026, 18:05Heghine Khachatryan: Rethinking Hemostatic Targets in Pregnancy for von Willebrand Disease
-
Apr 5, 2026, 17:45Matthew Walls: Recognising CAD PRS as a New ‘Risk Enhancing Factor’ in the 2026 ACC/AHA Guidelines
-
Apr 5, 2026, 17:44Philip A. Chan: Occasional Heavy Drinking Leads to 3 Times Higher Liver Fibrosis Risk in MASLD
-
Apr 5, 2026, 17:42Josu de la Fuente: Real World Data Shows Significant Risk of Subsequent HCT in SCD and Thalassemia
-
Apr 5, 2026, 17:41Gevorg Yaghjyan: Attending an AI Conference on AI in Clinical Medicine, Research and Education
-
Apr 5, 2026, 17:41Ifeanyichukwu Ifechidere: The Mastermind of Clotting – A Thrombin Story
-
Apr 5, 2026, 17:38Thomas Ichim: Making iPSC Cells from Menstrual Blood Stem Cells